The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2016 | The importance of educating stem cell transplant recipients on tuberculosis and cytomegalovirus
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the importance of educating stem cell transplant patients on the risk of tuberculosis and cytomegalovirus (CMV) infections. Prof. Chemaly describes why it is important to ask patients the right questions in order to establish whether they may have been exposed to tuberculosis (TB) in the past. Prof Chemaly also discusses the CMV and the risk it can pose to stem cell transplant recipients. According to Prof. Chemaly it is important to make sure the patient understands the seriousness of these infections as it is crucial to catch the infection early. He further describes the recommendations he gives to patients, such as wearing a mask and washing their hands frequently, in order to avoid infection.
Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
